Phase I Study of SB751689 [ronacaleret] - Single and Multiple Oral Dose Study in Japanese Postmenopausal Women.
Phase of Trial: Phase I
Latest Information Update: 05 Sep 2018
At a glance
- Drugs Ronacaleret (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 14 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Nov 2007 New trial record.